V
Vincent C. O. Njar
Researcher at University of Maryland, Baltimore
Publications - 154
Citations - 10648
Vincent C. O. Njar is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Prostate cancer & Androgen receptor. The author has an hindex of 42, co-authored 146 publications receiving 9790 citations. Previous affiliations of Vincent C. O. Njar include Saarland University & University of Maryland Marlene and Stewart Greenebaum Cancer Center.
Papers
More filters
Journal ArticleDOI
Abstract LB235: Mechanistic studies on VNLG-152R-mediated tumor inhibition of triple negative breast cancer
TL;DR: Thomas et al. as discussed by the authors reported that VNLG-152R significantly upregulates Synoviolin (SYVN1) with concomitant degradation of Mnk1/2.
Journal ArticleDOI
SYNTHESES OF (15α-2H)-, (15β-2H)-, AND (15-2H2)PROGESTERONE
Journal ArticleDOI
Synthesis of 6α,7α‐ and 6β,7β‐Aziridinoandrost‐4‐ ene‐3,17‐diones and Related Compounds: Potential Aromatase Inhibitors.
TL;DR: In this article, the synthesis of 6β,7β- and 6α, 7α-aziridinoandrost-4-ene-3β,17β-dione is described.
Patent
Retinamide and uses thereof
TL;DR: The retinamide RAMBAs are potent inhibitors of the growth of prostate and breast cancer cells and may be useful for the treatment of these diseases in humans as discussed by the authors. But they are not suitable for use in medical applications.
Patent
Steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
TL;DR: Nonsteroid and steroid compounds that cause downregulation of the androgen receptor (AR), both full length and splice variant, induce apoptosis and inhibit proliferation of inhibiting proliferation and migration of androgen sensitive cancer cells.